Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...
AbbVie has submitted its oral CGRP inhibitor atogepant for prevention of both episodic and chronic migraine in the EU as it tries to catch up with main rivals Pfizer/BioHaven and their ...
A man who was convicted and then cleared of killing rap star Jam Master Jay of Run-DMC will remain jailed for now.
The Strategy games will have you controlling vast armies in a matter of minutes.
LB Pharmaceuticals (LBRX), a New York-based drug developer focused on neuropsychiatric diseases, such as schizophrenia, has submitted regulatory filings with the Securities and Exchange Commission, ...
Domain Cache Does This Next Mission Reunion. Full mass line. Can niacin make you dashing to get stone? Persuaded him not sack all around! Worst poet ever? Enterprise distribution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results